Fig. 1From: Prevalence of vaccine-derived hepatitis B surface antibodies in children and adolescents in Germany: results from a population-based survey, 2014–2017Time since last dose (in years) and anti-HBs level (N = 2,472*). *17 samples had anti-HBs values above the upper detection limit and were excluded from Figure 1Back to article page